Read More Pharma Industry News Viking Therapeutics initiates VOYAGE study for VK2809 in NASH Viking Therapeutics has initiated the VOYAGE study, a phase 2b clinical trial of its liver-selective thyroid hormone receptor… bypharmanewsdailyNovember 20, 2019
